Viseon

About:

Viseon is a privately held medical device company committed to developing proprietary technology.

Website: http://www.viseon-spine.com/

Top Investors: Invus, Wexford Capital, HBM-MedFocus

Description:

Viseon is a privately held medical device company committed to developing proprietary technology for use in Minimally Invasive Spine Surgery (MISS) procedures. Viseon has progressed rapidly over the past 6-months, having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive spine surgery procedures. In addition to rapid product development of its initial products, Viseon has assembled a world-class Scientific Advisory Board of leading MISS physicians, amassed 13 patents to solidify its intellectual property platform, and completed a series of pre-clinical studies supporting initial human-use, scheduled to begin soon. Viseon was founded in early 2017 as a spin-out from Rebound Therapeutics Corporation.

Total Funding Amount:

$23M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Irvine, California, United States

Founded Date:

2017-04-03

Contact Email:

customerservice(AT)viseon-spine.com

Founders:

Alex Thomson, Lisa Zindel

Number of Employees:

11-50

Last Funding Date:

2024-06-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai